Soluble guanylate cyclase stimulation reduces oxidative stress in experimental Chronic Obstructive Pulmonary Disease

PLoS One. 2018 Jan 5;13(1):e0190628. doi: 10.1371/journal.pone.0190628. eCollection 2018.

Abstract

Objective: Soluble guanylate cyclase (sGC) is a key enzyme of the nitric oxide-cyclic guanosine 3',5'-monophosphate (NO-cGMP) signaling pathway, and its pharmacological stimulation has been shown to prevent the development of emphysema and pulmonary vascular remodeling in animal models of chronic obstructive pulmonary disease (COPD). The aim of this study was to evaluate the effects of sGC stimulation on oxidative stress in the plasma of guinea pigs chronically exposed to cigarette smoke (CS).

Methods and results: Guinea pigs were exposed to CS or sham for three months, and received either the sGC stimulator BAY 41-2272 or vehicle. Body weight was measured weekly; and markers of oxidative stress in plasma, and airspace size and inflammatory cell infiltrate in lung tissue were analyzed at the end of the study. Compared to sham-exposed guinea pigs, CS-exposed animals gained less body weight and showed higher plasma levels of nitrated tyrosine residues (3-NT), 4-hydroxynonenal (4-HNE), and 8-hydroxydeoxyguanosine (8-OHdG). Treatment with the sGC stimulator led to a body weight gain in the CS-exposed guinea pigs similar to non-exposed and attenuated the increase in 3-NT and 4-HNE. Plasma levels of 3-NT correlated with the severity of inflammatory cell infiltrate in the lung.

Conclusion: Stimulation of sGC prevents oxidative stress induced by CS exposure and is associated with an attenuated inflammatory response in the lung.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Animals
  • Biomarkers / blood
  • Cigarette Smoking
  • Enzyme Activation
  • Guinea Pigs
  • Lung / enzymology
  • Lung / metabolism
  • Male
  • Oxidative Stress*
  • Pulmonary Disease, Chronic Obstructive / blood
  • Pulmonary Disease, Chronic Obstructive / enzymology
  • Pulmonary Disease, Chronic Obstructive / metabolism*
  • Smoke
  • Soluble Guanylyl Cyclase / metabolism*

Substances

  • Biomarkers
  • Smoke
  • Soluble Guanylyl Cyclase

Grants and funding

The study has been funded by grants from the Instituto de Salud Carlos III (PS09/0536, PI14/00713 and PI16/01147), an unrestricted educational grant from Bayer AG, the Spanish Society of Respiratory Medicine (SEPAR) (24/2015 and /2016) and Catalan Foundation of Pulmonology (FUCAP) (FUCAP 2016). Cofinanciado por el Fondo Europeo de Desarrollo Regional (FEDER). Unión Europea. “Una manera de hacer Europa”. O. Tura-Ceide was the recipient of IDIBAPS-Biotrack postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.